Moderna (BSP:M1RN34) Other Long Term Assets : R$2,903 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Moderna Other Long Term Assets?

Moderna's other long-term assets for the quarter that ended in Mar. 2024 was R$2,903 Mil.

Moderna's quarterly other long-term assets increased from Sep. 2023 (R$2,361 Mil) to Dec. 2023 (R$2,959 Mil) but then stayed the same from Dec. 2023 (R$2,959 Mil) to Mar. 2024 (R$2,903 Mil).

Moderna's annual other long-term assets increased from Dec. 2021 (R$2,104 Mil) to Dec. 2022 (R$10,113 Mil) but then declined from Dec. 2022 (R$10,113 Mil) to Dec. 2023 (R$2,959 Mil).

Moderna Other Long Term Assets Historical Data

The historical data trend for Moderna's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moderna Other Long Term Assets Chart

Moderna Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long Term Assets

Get a 7-Day Free Trial

52.22

66.88

2,103.62

10,113.13

2,959.48

Moderna Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long Term Assets	Get a 7-Day Free Trial															11,682.89	12,391.50	2,360.70	2,959.48	2,903.22

Moderna Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Moderna (BSP:M1RN34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Moderna Inc (BSP:M1RN34) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

MRNA:USA MRNA:Peru MRNA:Mexico 0QFd:UK 0A45:UK 0QF:Germany MRNA:Austria

Address

200 Technology Square, Cambridge, MA, USA, 02139

Website

https://www.modernatx.com

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 39 mRNA development candidates in clinical trials as of mid-2023. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

Moderna (BSP:M1RN34) Headlines

No Headlines